5 hours ago
For the past couple of decades, the so-called "American Dream" has followed a pretty linear pathway. You finish high school, go to a four-year university, and then graduate straight into a corporate office that comes with a slick 401(k).
That bachelor's degree was the golden ticket that made everything possible, and your parents probably told you that earning a diploma was critical to your success, right? Well, new labor market data has turned that decades-old playbook upside down.
Here's Another Little-Known Firm Jensen Huang's Nvidia Is Quietly Backing
MediaTek Is Stepping Up Competition Against Qualcomm With a New 2-Nanometer Chip. What This Means for QCOM Stock.
1 Year Into the Microsoft Deal, IREN Is Delivering and a Rally May Follow Soon
#firm #jensen
That bachelor's degree was the golden ticket that made everything possible, and your parents probably told you that earning a diploma was critical to your success, right? Well, new labor market data has turned that decades-old playbook upside down.
Here's Another Little-Known Firm Jensen Huang's Nvidia Is Quietly Backing
MediaTek Is Stepping Up Competition Against Qualcomm With a New 2-Nanometer Chip. What This Means for QCOM Stock.
1 Year Into the Microsoft Deal, IREN Is Delivering and a Rally May Follow Soon
#firm #jensen
13 hours ago
It's been a disappointing couple of years for shareholders of biotechnology outfit CRISPR Therapeutics (NASDAQ: CRSP). This stock's barely up since the end of 2022, lagging the broad market's gains. It's not the performance that investors keeping tabs on this company were expecting, given its potential.
Don't be discouraged, though. While still speculative like most young biotech names, CRISPR Therapeutics remains a compelling prospect for investors who can stomach the risk and its inevitable volatility. Here's why.
Missed AI's "Act 1"? Act 2 Could Be 15x Bigger. Most investors think they missed the AI boat because they didn't buy Nvidia in 2005. But according to our **** ysts, we're only at the end of "Act 1"—the R&D phase. "Act 2" is the global rollout. Continue »
On the off-chance you're reading this and aren't already familiar with the company, CRISPR Therapeutics is a drug developer that specializes in gene editing.
It's probably an area you've heard a great deal about. No gene-editing drugs were actually on the market in the United States until CRISPR Therapeutics' Casgevy was approved by the FDA as a treatment for sickle cell disease in late 2023. Any and all gene therapies currently on the market followed this pioneer's foray. Being first is a well-deserved accolade for the company, too, which was co-founded by Dr. Emmanuelle Charpentier, who was one of the co-discoverers of the CRISPR/Cas9 gene-editing mechanism that makes Casgevy work.
#crispr #gene #company
Don't be discouraged, though. While still speculative like most young biotech names, CRISPR Therapeutics remains a compelling prospect for investors who can stomach the risk and its inevitable volatility. Here's why.
Missed AI's "Act 1"? Act 2 Could Be 15x Bigger. Most investors think they missed the AI boat because they didn't buy Nvidia in 2005. But according to our **** ysts, we're only at the end of "Act 1"—the R&D phase. "Act 2" is the global rollout. Continue »
On the off-chance you're reading this and aren't already familiar with the company, CRISPR Therapeutics is a drug developer that specializes in gene editing.
It's probably an area you've heard a great deal about. No gene-editing drugs were actually on the market in the United States until CRISPR Therapeutics' Casgevy was approved by the FDA as a treatment for sickle cell disease in late 2023. Any and all gene therapies currently on the market followed this pioneer's foray. Being first is a well-deserved accolade for the company, too, which was co-founded by Dr. Emmanuelle Charpentier, who was one of the co-discoverers of the CRISPR/Cas9 gene-editing mechanism that makes Casgevy work.
#crispr #gene #company
18 hours ago
On August 10, Simon Property Group (NYSE:SPG) reported results for the three months through June 30 and raised its full-year profit outlook once again. Real estate funds from operations (FFO), a cash-flow measure suited to landlords, hit $3.29 per share. Tenants are earning more from their stores, and management is confident enough to lift its guidance again. Yet the professionals who own the stock are heading the other way.
Start with the tenants, because they pay the rent. Reported retailer sales reached $838 per square foot over the year through June 30, up from $736 a year earlier, on June 30, 2025. Stronger sales tend to make higher rent easier to swallow, and base minimum rent per square foot did climb to $62.42 from $58.70.
That demand flowed through to profit. Real estate FFO rose to $3.29 per diluted share from $3.05, and net operating income at Simon's domestic properties grew 8.5%. Management responded by lifting its full-year real estate FFO range to $13.20 to $13.30 per share, moving the midpoint up by $0.08.
Shareholders get paid while they wait. The board declared a third-quarter dividend of $2.25 per share, $0.10 more than a year ago, to be paid on September 30 to anyone on the books by September 9. Simon also put $211.4 million into buying back stock at an average of $205.10 per share, and it finished June with about $9.3 billion of liquidity.
Now the less flattering side. Net income for common stockholders was $483.1 million, or $1.49 per diluted share, versus $1.70 a year earlier. The 2025 quarter included a non-cash gain of $0.21 per share from investment activity, which flatters that comparison. Still, plain FFO followed the same path, slipping to $3.12 from $3.15.
#Share #year #june #estate
Start with the tenants, because they pay the rent. Reported retailer sales reached $838 per square foot over the year through June 30, up from $736 a year earlier, on June 30, 2025. Stronger sales tend to make higher rent easier to swallow, and base minimum rent per square foot did climb to $62.42 from $58.70.
That demand flowed through to profit. Real estate FFO rose to $3.29 per diluted share from $3.05, and net operating income at Simon's domestic properties grew 8.5%. Management responded by lifting its full-year real estate FFO range to $13.20 to $13.30 per share, moving the midpoint up by $0.08.
Shareholders get paid while they wait. The board declared a third-quarter dividend of $2.25 per share, $0.10 more than a year ago, to be paid on September 30 to anyone on the books by September 9. Simon also put $211.4 million into buying back stock at an average of $205.10 per share, and it finished June with about $9.3 billion of liquidity.
Now the less flattering side. Net income for common stockholders was $483.1 million, or $1.49 per diluted share, versus $1.70 a year earlier. The 2025 quarter included a non-cash gain of $0.21 per share from investment activity, which flatters that comparison. Still, plain FFO followed the same path, slipping to $3.12 from $3.15.
#Share #year #june #estate
1 day ago
The first full week of trading in September didn't give Zscaler (NASDAQ: ZS) investors much to celebrate. During the shortened trading week that followed Labor Day, Zscaler dropped about 3%. This week, however, is a very different story, thanks to a firm providing an auspicious outlook for the cybersecurity stock.
According to data provided by S&P Global Market Intelligence, Zscaler shares were up 20.7% from the end of trading last Friday through 3:37 p.m. today.
Missed AI's "Act 1"? Act 2 Could Be 15x Bigger. Most investors think they missed the AI boat because they didn't buy Nvidia in 2005. But according to our ******* ysts, we're only at the end of "Act 1"—the R&D phase. "Act 2" is the global rollout. Continue »
Maintaining its outperform rating, Bernstein hiked its price target on Zscaler stock to $298 from $224 on Thursday morning. Based on Zscaler's closing price of $191.58 on Wednesday, the Bernstein price target implies 56% upside.
According to Thefly.com, Bernstein based its improved outlook on the belief that there's growing positive market sentiment toward cybersecurity stocks. In addition, Bernstein notes that cybersecurity stocks it had previously identified as "too cheap" are now reasonable valued, yet Zscaler is one option that still provides material upside.
#week
According to data provided by S&P Global Market Intelligence, Zscaler shares were up 20.7% from the end of trading last Friday through 3:37 p.m. today.
Missed AI's "Act 1"? Act 2 Could Be 15x Bigger. Most investors think they missed the AI boat because they didn't buy Nvidia in 2005. But according to our ******* ysts, we're only at the end of "Act 1"—the R&D phase. "Act 2" is the global rollout. Continue »
Maintaining its outperform rating, Bernstein hiked its price target on Zscaler stock to $298 from $224 on Thursday morning. Based on Zscaler's closing price of $191.58 on Wednesday, the Bernstein price target implies 56% upside.
According to Thefly.com, Bernstein based its improved outlook on the belief that there's growing positive market sentiment toward cybersecurity stocks. In addition, Bernstein notes that cybersecurity stocks it had previously identified as "too cheap" are now reasonable valued, yet Zscaler is one option that still provides material upside.
#week
1 day ago
In June, ****** eX (NASDAQ: SPCX) successfully completed its blockbuster IPO, raising more than $85 billion. In the days that followed, ****** eX's market cap soared from an initial IPO valuation of $1.77 trillion to nearly $2.8 trillion. Shares corrected hard after the surge, however, and ****** eX's valuation now hovers just below $2 trillion -- a 36% decline versus the company's all-time high.
Morgan Stanley (NYSE: MS) ****** ysts remain unfazed regarding the ****** e stock's long-term growth potential. On Sept. 15, the bank reiterated its "buy" rating on shares, affirming its $300 price target. That price target implies more than 100% in near-term upside over the next 12 months.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
Why does Morgan Stanley remain so bullish? The answer might surprise you.
Morgan Stanley appears all-in on the ****** e economy. The bank, in many ways, predicted ****** eX's meteoric rise years before much of the public caught on.
#trillion #valuation
Morgan Stanley (NYSE: MS) ****** ysts remain unfazed regarding the ****** e stock's long-term growth potential. On Sept. 15, the bank reiterated its "buy" rating on shares, affirming its $300 price target. That price target implies more than 100% in near-term upside over the next 12 months.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
Why does Morgan Stanley remain so bullish? The answer might surprise you.
Morgan Stanley appears all-in on the ****** e economy. The bank, in many ways, predicted ****** eX's meteoric rise years before much of the public caught on.
#trillion #valuation
1 day ago
XRP shook off a sharp regulatory setback this week, climbing more than 7% over 24 hours to trade near $1.39 after briefly touching lows around $1.27.
The rebound followed a rocky 48 hours that combined a failed Senate vote with the Federal Reserve's first rate hike since 2023.
Cloture is the Senate procedure required to end debate and move a bill toward a final vote, needing 60 senators to succeed. On September 15, the CLARITY Act fell short in a narrow 50-49 tally, missing that threshold and stalling a proposed federal framework for digital **** ets.
XRP dropped more than 8% in the immediate aftermath, touching lows near $1.27 to $1.28. Pressure intensified the next day when the Fed raised its benchmark rate by 25 basis points to a range of 3.75% to 4.00%, a move that typically weighs on risk **** ets broadly.
The sell-off, however, proved short-lived. XRP has since rebounded to $1.39, up 7.23% over 24 hours, even as the token slipped slightly by 0.30% in the past hour. Trading volume held near $3.9 billion, close to its 30-day average, suggesting genuine buying rather than thin, low-liquidity trading.
#near #senate #since
The rebound followed a rocky 48 hours that combined a failed Senate vote with the Federal Reserve's first rate hike since 2023.
Cloture is the Senate procedure required to end debate and move a bill toward a final vote, needing 60 senators to succeed. On September 15, the CLARITY Act fell short in a narrow 50-49 tally, missing that threshold and stalling a proposed federal framework for digital **** ets.
XRP dropped more than 8% in the immediate aftermath, touching lows near $1.27 to $1.28. Pressure intensified the next day when the Fed raised its benchmark rate by 25 basis points to a range of 3.75% to 4.00%, a move that typically weighs on risk **** ets broadly.
The sell-off, however, proved short-lived. XRP has since rebounded to $1.39, up 7.23% over 24 hours, even as the token slipped slightly by 0.30% in the past hour. Trading volume held near $3.9 billion, close to its 30-day average, suggesting genuine buying rather than thin, low-liquidity trading.
#near #senate #since
1 day ago
Super Micro Computer (SMCI) stock rose 9.5% on Thursday, September 17, closing just over $40. The move followed a bullish call on how big the market for AI servers gets. That call may well be right. But it answers a question Super Micro's own results never raised. That is why one big session tells you less than it looks like it does.
Analysts at Goldman Sachs said the addressable market for AI servers will expand aggressively through the end of the decade. That is a forecast about an industry rather than about one manufacturer. Another account of Thursday morning's climb credited a broader equity rebound after Wednesday afternoon's Federal Reserve rate decision, not the forecast. Hewlett Packard Enterprise (HPE) jumped 8.0% the same day against the S&P 500's 1.1% gain, showing that capital was rotating heavily into primary AI server makers.
Company-specific headlines that day ran the other way: after the close, a shareholder rights law firm issued a press release soliciting clients for a potential investigation into company management.
A bigger market is not what this company is short of. In its fiscal fourth quarter, ended June 2026, Super Micro booked over $60 billion of new orders. That backlog underpins management's fiscal 2027 revenue guidance of $65 billion to $72 billion—up sharply from the $39 billion booked over the prior twelve months, but spread out as delivery and deployment constraints allow customers to take delivery.
What it is short of is customers ready to take delivery. Super Micro sells data center building block solutions, which bundle the servers with the power, cooling, networking and software around them. The company's manufacturing capability is on track to include more than 3,000 direct liquid-cooled racks a month.
#forecast
Analysts at Goldman Sachs said the addressable market for AI servers will expand aggressively through the end of the decade. That is a forecast about an industry rather than about one manufacturer. Another account of Thursday morning's climb credited a broader equity rebound after Wednesday afternoon's Federal Reserve rate decision, not the forecast. Hewlett Packard Enterprise (HPE) jumped 8.0% the same day against the S&P 500's 1.1% gain, showing that capital was rotating heavily into primary AI server makers.
Company-specific headlines that day ran the other way: after the close, a shareholder rights law firm issued a press release soliciting clients for a potential investigation into company management.
A bigger market is not what this company is short of. In its fiscal fourth quarter, ended June 2026, Super Micro booked over $60 billion of new orders. That backlog underpins management's fiscal 2027 revenue guidance of $65 billion to $72 billion—up sharply from the $39 billion booked over the prior twelve months, but spread out as delivery and deployment constraints allow customers to take delivery.
What it is short of is customers ready to take delivery. Super Micro sells data center building block solutions, which bundle the servers with the power, cooling, networking and software around them. The company's manufacturing capability is on track to include more than 3,000 direct liquid-cooled racks a month.
#forecast
2 days ago
Choosing between a niche equipment provider and a diversified industry **** an requires balancing high growth potential against established stability. Here is how Aehr Test Systems (NASDAQ:AEHR) and KLA (NASDAQ:KLAC) compare for investors.
Aehr Test Systems focuses on specific stress-testing solutions for power semiconductors and memory, while KLA provides broad process control tools used across the entire chip-making industry. While they both operate in the same sector, their scale and risk profiles differ significantly, making them attractive to different types of portfolios.
Aehr Test Systems designs and sells specialized equipment for the testing and stabilization of semiconductor products in various forms, including wafers and singulated dies. The company focuses on the high-growth silicon carbide market for electric vehicles and high-bandwidth memory for artificial intelligence infrastructure. In its 2026 fiscal year (FY), which ended May 29, its five largest customers accounted for nearly 70% of net sales, and customer concentration like this adds a layer of risk to the business.
In FY 2026, revenue reached $50.0 million, representing a decline of 15.2% compared to the previous year. This contraction followed a period of higher operating costs, resulting in a net loss of $7.1 million for the period. The net margin, which represents the percentage of revenue remaining as profit after all expenses, was -14.3% in the latest fiscal year.
As of its May 2026 balance sheet, the debt-to-equity ratio is zero, indicating that the company has no debt relative to its shareholder equity. The current ratio, which measures a company's ability to cover short-term liabilities with short-term **** ets, is 10.3x. Free cash flow, defined as cash from operations minus capital expenditures, was a negative $5.4 million for the fiscal year ended in May.
#year #equipment
Aehr Test Systems focuses on specific stress-testing solutions for power semiconductors and memory, while KLA provides broad process control tools used across the entire chip-making industry. While they both operate in the same sector, their scale and risk profiles differ significantly, making them attractive to different types of portfolios.
Aehr Test Systems designs and sells specialized equipment for the testing and stabilization of semiconductor products in various forms, including wafers and singulated dies. The company focuses on the high-growth silicon carbide market for electric vehicles and high-bandwidth memory for artificial intelligence infrastructure. In its 2026 fiscal year (FY), which ended May 29, its five largest customers accounted for nearly 70% of net sales, and customer concentration like this adds a layer of risk to the business.
In FY 2026, revenue reached $50.0 million, representing a decline of 15.2% compared to the previous year. This contraction followed a period of higher operating costs, resulting in a net loss of $7.1 million for the period. The net margin, which represents the percentage of revenue remaining as profit after all expenses, was -14.3% in the latest fiscal year.
As of its May 2026 balance sheet, the debt-to-equity ratio is zero, indicating that the company has no debt relative to its shareholder equity. The current ratio, which measures a company's ability to cover short-term liabilities with short-term **** ets, is 10.3x. Free cash flow, defined as cash from operations minus capital expenditures, was a negative $5.4 million for the fiscal year ended in May.
#year #equipment
2 days ago
Leaving $650,000 in IRAs untouched for 11 years grew the balance to $1.11 million, forcing a $42,000 first-year RMD on top of pension income.
The couple missed 11 years of Roth conversion opportunities at the 12% rate, pushing RMD dollars into the 22% bracket instead.
When one spouse dies, the survivor files under single brackets where the 22% rate starts at $50,400, making the same RMD far more costly.
Two retirees, same $1 million, same 4% rule, buy one finished with $1.4 million, the other hit $0 in 12 years. Our free reader guide explains the flaw that separated them, and the income-first method built to avoid it.
Let's start by considering a couple retiring at 62. His pension covers the mortgage, the groceries, the property tax, and the trip to see the grandkids twice a year. Two traditional IRAs, hers and his, hold a combined $650,000 on the day they stop working, and they never take a distribution. Now imagine that eleven quiet years have passed, and then the first required minimum distribution letter arrives, followed by a second, and the number attached to those letters is larger than either of them planned for.
#iras
The couple missed 11 years of Roth conversion opportunities at the 12% rate, pushing RMD dollars into the 22% bracket instead.
When one spouse dies, the survivor files under single brackets where the 22% rate starts at $50,400, making the same RMD far more costly.
Two retirees, same $1 million, same 4% rule, buy one finished with $1.4 million, the other hit $0 in 12 years. Our free reader guide explains the flaw that separated them, and the income-first method built to avoid it.
Let's start by considering a couple retiring at 62. His pension covers the mortgage, the groceries, the property tax, and the trip to see the grandkids twice a year. Two traditional IRAs, hers and his, hold a combined $650,000 on the day they stop working, and they never take a distribution. Now imagine that eleven quiet years have passed, and then the first required minimum distribution letter arrives, followed by a second, and the number attached to those letters is larger than either of them planned for.
#iras
2 days ago
Are you worried enough about rising interest rates jump-starting a recession that you're looking for ways of sidestepping the effect of such an economic headwind? It's not a terrible idea to at least start making a mental plan for that possibility.
You may have considered Berkshire Hathaway (NYSE: BRKA) (NYSE: BRKB) to fill that role. Its wholly owned, private businesses generate plenty of cash flow regardless of the economic backdrop, after all.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
But how do Berkshire shares actually perform during recessions? It's not like the data doesn't exist.
You probably know Berkshire Hathaway best by its stock picks. Although they're not built to be an actively managed mutual fund, its equity holdings -- and changes to these holdings -- are closely followed by investors looking for some new ideas for their own portfolios.
#berkshire #signal #NYSE #flashing
You may have considered Berkshire Hathaway (NYSE: BRKA) (NYSE: BRKB) to fill that role. Its wholly owned, private businesses generate plenty of cash flow regardless of the economic backdrop, after all.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
But how do Berkshire shares actually perform during recessions? It's not like the data doesn't exist.
You probably know Berkshire Hathaway best by its stock picks. Although they're not built to be an actively managed mutual fund, its equity holdings -- and changes to these holdings -- are closely followed by investors looking for some new ideas for their own portfolios.
#berkshire #signal #NYSE #flashing
2 days ago
Some offers on this page are from advertisers who pay us, which may affect which products we write about, but not our recommendations. See our Advertiser Disclosure.
The Federal Reserve raised interest rates, and whether directly related or not, mortgage rates followed. With home loan rates now effectively at 7%, what will it take for mortgage rates to reverse course and move lower?
See today's best rates.
No. As of Sept. 17, Freddie Mac reported that the average 30-year fixed-rate mortgage rate was 6.95%. This is 19 basis points higher than last week. At this time in September 2025, mortgage rates averaged 6.26%, 69 basis points lower.
The average 15-year fixed mortgage rate this week was 6.26%, up 17 basis points from last week, and 85 basis points higher than this time last year.
#basis #points
The Federal Reserve raised interest rates, and whether directly related or not, mortgage rates followed. With home loan rates now effectively at 7%, what will it take for mortgage rates to reverse course and move lower?
See today's best rates.
No. As of Sept. 17, Freddie Mac reported that the average 30-year fixed-rate mortgage rate was 6.95%. This is 19 basis points higher than last week. At this time in September 2025, mortgage rates averaged 6.26%, 69 basis points lower.
The average 15-year fixed mortgage rate this week was 6.26%, up 17 basis points from last week, and 85 basis points higher than this time last year.
#basis #points
2 days ago
Autodesk (ADSK) stock has 23.6% of room above it before it meets a ceiling that has turned it back three times, and 5% below it before the reason to be there stops being true. In dollars: $272.34 overhead, $220.31 Wednesday, $209.29 underneath. The stock has lost about 31% over the past twelve months, so the easy read is that the business broke. Its own numbers say it did not.
Would You Have Made Money Buying Autodesk Here Before?
Buyers have stepped in at this price zone eight times before. Three of those eight produced a completed advance, averaging a 34.3% gain to the peak that followed, with a median of 459 days from the defense to that peak. The other five have not yet risen above their own starting price, so they are not in that average at all. The ceiling overhead asks for less than that average of the three that paid.
The last two years are the problem. Autodesk entered this price band on five separate occasions over the last twenty-four months, and counting only a 20% gain before any 5% fall as a defense, one held and four broke 5% lower first. The path up is not clear either: the stock has to get through $248.16 and $261.04, both pauses rather than proven ceilings.
Is Autodesk In Better Shape Than The Last Time It Sat Here?
#last #Stock #above #times
Would You Have Made Money Buying Autodesk Here Before?
Buyers have stepped in at this price zone eight times before. Three of those eight produced a completed advance, averaging a 34.3% gain to the peak that followed, with a median of 459 days from the defense to that peak. The other five have not yet risen above their own starting price, so they are not in that average at all. The ceiling overhead asks for less than that average of the three that paid.
The last two years are the problem. Autodesk entered this price band on five separate occasions over the last twenty-four months, and counting only a 20% gain before any 5% fall as a defense, one held and four broke 5% lower first. The path up is not clear either: the stock has to get through $248.16 and $261.04, both pauses rather than proven ceilings.
Is Autodesk In Better Shape Than The Last Time It Sat Here?
#last #Stock #above #times
2 days ago
Updated Sept 17, 2026, 4:16 pm EDT / Original Sept 17, 2026, 6:38 am EDT
Stocks rose Thursday
as oil prices and Treasury yields pulled back in a rebound from Wednesday’s selloff that followed the Federal Reserve’s
interest-rate increase
.
Copyright ©2026 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
U.S.-Canada energy trade already delivers energy security and abundance for consumers on a larger scale than Venezuela can provide, Ben Cahill writes.
#updated #stocks
Stocks rose Thursday
as oil prices and Treasury yields pulled back in a rebound from Wednesday’s selloff that followed the Federal Reserve’s
interest-rate increase
.
Copyright ©2026 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
U.S.-Canada energy trade already delivers energy security and abundance for consumers on a larger scale than Venezuela can provide, Ben Cahill writes.
#updated #stocks
2 days ago
Updated Sept. 17, 2026 2:46 pm ET
Listen
(3 min)
1443 ET – Precious metal futures settle higher in New York, recovering from a swoon in the wake of yesterday’s Federal Reserve interest-rate increase. “My sense is that they will lag while we’re in a rate-hiking cycle, and right now we’re fairly clearly in a rate-hiking cycle,” says David Russell, global head of market strategy at TradeStation. There are a lot of arguments in favor of gold, in terms of central bank buying and an alternative to the dollar, but the current macro environment “is not in any way textbook favorable for gold and silver,” he adds. Front-month gold settles up 0.3% to $4,360.20 a troy ounce, and silver rises 1.8% to $65.47 a troy ounce. (anthony.harrupwsj.com)
1118 ET – Gold futures recover losses that followed the Fed’s rate hike as Treasury yields move lower and the dollar slips, while oil prices extend their pullback to a second day. “Gold is rangebound with two-way risk, but the large bull market we had seen earlier in the year is considered on pause for now,” Pepperstone strategist Ahmad ******* iri says in a note. The bull market could continue at some stage with underlying drivers such as central bank demand, macro uncertainty, and fiscal concerns, he says. But “the path of oil prices and their transmission into Fed policy remains the single most important variable from now till year-end.” The December contract is up 0.4% in New York at $4,404.90 a troy ounce. Silver rises 2.3% to $66.44 a troy ounce. (anthony.harrupwsj.com)
#Gold #york #futures
Listen
(3 min)
1443 ET – Precious metal futures settle higher in New York, recovering from a swoon in the wake of yesterday’s Federal Reserve interest-rate increase. “My sense is that they will lag while we’re in a rate-hiking cycle, and right now we’re fairly clearly in a rate-hiking cycle,” says David Russell, global head of market strategy at TradeStation. There are a lot of arguments in favor of gold, in terms of central bank buying and an alternative to the dollar, but the current macro environment “is not in any way textbook favorable for gold and silver,” he adds. Front-month gold settles up 0.3% to $4,360.20 a troy ounce, and silver rises 1.8% to $65.47 a troy ounce. (anthony.harrupwsj.com)
1118 ET – Gold futures recover losses that followed the Fed’s rate hike as Treasury yields move lower and the dollar slips, while oil prices extend their pullback to a second day. “Gold is rangebound with two-way risk, but the large bull market we had seen earlier in the year is considered on pause for now,” Pepperstone strategist Ahmad ******* iri says in a note. The bull market could continue at some stage with underlying drivers such as central bank demand, macro uncertainty, and fiscal concerns, he says. But “the path of oil prices and their transmission into Fed policy remains the single most important variable from now till year-end.” The December contract is up 0.4% in New York at $4,404.90 a troy ounce. Silver rises 2.3% to $66.44 a troy ounce. (anthony.harrupwsj.com)
#Gold #york #futures
2 days ago
Comments from Anthropic CEO Dario Amodei and OpenAI CEO Sam Altman calling for a more measured approach to frontier AI development contributed to a sharp selloff across neoclouds and data center stocks. Bernstein identified CoreWeave Inc. (NASDAQ:CRWV) as the most exposed name because of its rural footprint and focus on AI training. The concern represents a genuine structural argument. However, it marks the second time this year that the same group of stocks has faced concerns over the sustainability of AI demand. There is also an important tension within Bernstein's own note, which highlights CoreWeave's exposure while acknowledging that most of its backlog remains shielded by contracts.
Bernstein cautioned that a slowdown in AI training could weigh on data center developers. The warning followed Amodei's weekend comments urging the industry to deliberately slow the pace of frontier AI capability gains, along with similar remarks from Sam Altman. According to ****** yst Madison Rezaei, slower training activity would likely reduce demand for rural data center sites designed for latency-insensitive workloads. The ****** yst pointed out that rural and Tier 3 markets account for 70% of the industry's 488GW pipeline. CoreWeave was identified as the most exposed name in the firm's coverage. ****** yst Madison Rezaei remarked:
We estimate that 25% of their existing active U.S. power, with an additional ~74% of their contracted power, is situated in Tier 3 and Tier 4 markets.
However, there is a key counterpoint within Bernstein's own note:
The backlog is primarily comprised of take-or-pay contracts, so we do not anticipate a threat there but could see a pullback in demand for the contracted-not-yet-sold rural power if training development slows.
#training #analyst
Bernstein cautioned that a slowdown in AI training could weigh on data center developers. The warning followed Amodei's weekend comments urging the industry to deliberately slow the pace of frontier AI capability gains, along with similar remarks from Sam Altman. According to ****** yst Madison Rezaei, slower training activity would likely reduce demand for rural data center sites designed for latency-insensitive workloads. The ****** yst pointed out that rural and Tier 3 markets account for 70% of the industry's 488GW pipeline. CoreWeave was identified as the most exposed name in the firm's coverage. ****** yst Madison Rezaei remarked:
We estimate that 25% of their existing active U.S. power, with an additional ~74% of their contracted power, is situated in Tier 3 and Tier 4 markets.
However, there is a key counterpoint within Bernstein's own note:
The backlog is primarily comprised of take-or-pay contracts, so we do not anticipate a threat there but could see a pullback in demand for the contracted-not-yet-sold rural power if training development slows.
#training #analyst
2 days ago
President Trump was photographed this week on board Air Force One examining a large poster with the words "Kennedy Center DEMOLISHED" printed above a rendering of a construction site, heightening concerns that his administration wants to raze Washington, D.C.'s iconic performing arts venue if his name is not added to its facade.
"I think that the Trump administration should certainly have recognition," the president told reporters before he boarded the plane Wednesday in North Carolina. "Because frankly, if we don't do that, it's going to close. It'll end up being ripped down."
Trump's comments and the photographs that followed are the latest developments in a convoluted saga that started when he dismissed the center's trustees in February 2025 — just days after returning to office — and replaced them with loyalists who elected him chairman.
Despite several legal setbacks, Trump's handpicked board has been pushing ever since to rename the John F. Kennedy Center for the Performing Arts, which was built as a "living memorial" to the slain 35th president, after the White House's current occupant.
The day before Trump was photographed with the "Kennedy Center DEMOLISHED" poster, his appointees voted to close the center's main building for renovations. Does this mean Trump will bulldoze the Kennedy Center if he doesn't get the "recognition" he wants? Here's what we know — and what we don't.
#performing
"I think that the Trump administration should certainly have recognition," the president told reporters before he boarded the plane Wednesday in North Carolina. "Because frankly, if we don't do that, it's going to close. It'll end up being ripped down."
Trump's comments and the photographs that followed are the latest developments in a convoluted saga that started when he dismissed the center's trustees in February 2025 — just days after returning to office — and replaced them with loyalists who elected him chairman.
Despite several legal setbacks, Trump's handpicked board has been pushing ever since to rename the John F. Kennedy Center for the Performing Arts, which was built as a "living memorial" to the slain 35th president, after the White House's current occupant.
The day before Trump was photographed with the "Kennedy Center DEMOLISHED" poster, his appointees voted to close the center's main building for renovations. Does this mean Trump will bulldoze the Kennedy Center if he doesn't get the "recognition" he wants? Here's what we know — and what we don't.
#performing
3 days ago
On Wednesday, OpenAI (OPAI.PVT) revealed six new examples of its AI models displaying "unexpected or concerning model behavior" during testing and evaluation.
The company made the announcement alongside a new framework for "tracking, reporting, and disclosing" instances where AI models take actions they otherwise aren't told to or shouldn't.
It follows a number of reports of AI models from companies hacking into third-party networks and services, including an unreleased OpenAI model breaking into the network of AI model and testing site Hugging Face.
Earlier this week, Anthropic (ANTH.PVT) CEO Dario Amodei penned a lengthy essay calling for a slowdown in the pace of the development of frontier AI models, after Anthropic researcher Jacob ******* on posted on X that he was resigning from the company because it, and his former employer OpenAI, is "racing straight to self-improving superintelligence and gambling with our lives."
Anthropic alignment science lead Evan Hubinger followed up on ******* on's comments with his own post on X saying that he believes there is a greater-than-10% chance that the technology could "kill all humans."
#face
The company made the announcement alongside a new framework for "tracking, reporting, and disclosing" instances where AI models take actions they otherwise aren't told to or shouldn't.
It follows a number of reports of AI models from companies hacking into third-party networks and services, including an unreleased OpenAI model breaking into the network of AI model and testing site Hugging Face.
Earlier this week, Anthropic (ANTH.PVT) CEO Dario Amodei penned a lengthy essay calling for a slowdown in the pace of the development of frontier AI models, after Anthropic researcher Jacob ******* on posted on X that he was resigning from the company because it, and his former employer OpenAI, is "racing straight to self-improving superintelligence and gambling with our lives."
Anthropic alignment science lead Evan Hubinger followed up on ******* on's comments with his own post on X saying that he believes there is a greater-than-10% chance that the technology could "kill all humans."
#face
3 days ago
Stocks slid Wednesday afternoon after Federal Reserve Chair Kevin Warsh followed the central bank's first rate hike in three years with a press conference that hinted it wouldn't be the last.
The S&P 500 dropped 1%, heading toward its lowest close since July. The Dow Jones Industrial Average fell 1.7%, or more than 700 points, with financial shares leading the decline. The Nasdaq Composite fell 0.8%. The 10-year Treasury yield held near 5% a day after touching its highest level since 2007, and the dollar index climbed 0.6% to its strongest since late July.
Markets had priced in the quarter-point increase itself and initially took it in stride. All three indexes were higher before the 2 p.m. decision. The selling started during the press conference.
Warsh was on a tightrope going in. The question was whether he'd frame the hike as a one-off adjustment—which risked the bond market reading it as too little to deter inflation—or as the start of a longer cycle. He did neither, and instead went in a more hawkish direction. "I would be hard pressed to describe broad financial conditions as restrictive," he said in his opening remarks. "This view was widely shared by the committee, so we removed a dose of accommodation."
That's a new way of describing a rate hike, and one investors aren't used to. Under his predecessor, Jerome Powell, the Fed called policy "modestly restrictive," meaning rates were already high enough to slow the economy. Warsh was saying that at 3.5%–3.75%, they weren't—and by implication, one quarter point may not have gotten them there either. Asked directly, he declined to say whether policy is restrictive now.
#hike #press
The S&P 500 dropped 1%, heading toward its lowest close since July. The Dow Jones Industrial Average fell 1.7%, or more than 700 points, with financial shares leading the decline. The Nasdaq Composite fell 0.8%. The 10-year Treasury yield held near 5% a day after touching its highest level since 2007, and the dollar index climbed 0.6% to its strongest since late July.
Markets had priced in the quarter-point increase itself and initially took it in stride. All three indexes were higher before the 2 p.m. decision. The selling started during the press conference.
Warsh was on a tightrope going in. The question was whether he'd frame the hike as a one-off adjustment—which risked the bond market reading it as too little to deter inflation—or as the start of a longer cycle. He did neither, and instead went in a more hawkish direction. "I would be hard pressed to describe broad financial conditions as restrictive," he said in his opening remarks. "This view was widely shared by the committee, so we removed a dose of accommodation."
That's a new way of describing a rate hike, and one investors aren't used to. Under his predecessor, Jerome Powell, the Fed called policy "modestly restrictive," meaning rates were already high enough to slow the economy. Warsh was saying that at 3.5%–3.75%, they weren't—and by implication, one quarter point may not have gotten them there either. Asked directly, he declined to say whether policy is restrictive now.
#hike #press
3 days ago
AI poster-child Nvidia (NVDA) has jumped 14% year to date, but the ride's been noticeably ******* py according to Seeking Alpha data.
The stock's down nearly 6% in just one week and around the same amount over the past month, a pullback that has coincided with fresh questions over whether the breakneck AI buildout could finally lose momentum.
Consequently, that debate followed calls from some of the biggest names in AI to slow the development of frontier models for safety reasons. But on his latest "Mad Money" broadcast from Dreamforce, veteran ******* yst Jim Cramer made clear he's viewing Nvidia stock through a very different lens.
That's not hard to fathom because Nvidia continues giving bulls ammunition. Fiscal Q2 revenue more than doubled to $96.2 billion, with its Data Center business reaching $89 billion, as it pushes deeper into enterprise AI, including Salesforce's (CRM) new Koa reasoning model built on Nvidia Nemotron.
Cramer's takeaway after a sit-down with CEO Jensen Huang was hardly cautious, though. Instead of treating the latest AI scare as a reason to jump in and out of Nvidia, he framed the stock as something investors need to hold through the noise instead of trade.
#down #latest #billion
The stock's down nearly 6% in just one week and around the same amount over the past month, a pullback that has coincided with fresh questions over whether the breakneck AI buildout could finally lose momentum.
Consequently, that debate followed calls from some of the biggest names in AI to slow the development of frontier models for safety reasons. But on his latest "Mad Money" broadcast from Dreamforce, veteran ******* yst Jim Cramer made clear he's viewing Nvidia stock through a very different lens.
That's not hard to fathom because Nvidia continues giving bulls ammunition. Fiscal Q2 revenue more than doubled to $96.2 billion, with its Data Center business reaching $89 billion, as it pushes deeper into enterprise AI, including Salesforce's (CRM) new Koa reasoning model built on Nvidia Nemotron.
Cramer's takeaway after a sit-down with CEO Jensen Huang was hardly cautious, though. Instead of treating the latest AI scare as a reason to jump in and out of Nvidia, he framed the stock as something investors need to hold through the noise instead of trade.
#down #latest #billion
3 days ago
CorpGov is pleased to share the final agenda for the 2nd LA CorpGov Forum, to be held on Friday, Sept. 18, 2026 at The Huntington Library in San Marino, California. The conference registration will begin at 1:00pm and feature an afternoon of panels, firesides and networking, followed by a reception at 5:00pm with ***** tails and hors d'oeuvres in the Garden Court.
This event will bring together members of the financial community from both LA and beyond to join panels focused on the finance of entertainment and media, sports, along with capital markets and shareholder activism.
We invite institutional investors and corporate executives to attend and they may register at the link below. For more information, please email EditorCorpGov.com.
2:00PM: Best Practices in Sports Investing
Thomas W. Hulick, CEO, Managing Partner, Strategy ***** et Managers
#sports #Friday #library #california
This event will bring together members of the financial community from both LA and beyond to join panels focused on the finance of entertainment and media, sports, along with capital markets and shareholder activism.
We invite institutional investors and corporate executives to attend and they may register at the link below. For more information, please email EditorCorpGov.com.
2:00PM: Best Practices in Sports Investing
Thomas W. Hulick, CEO, Managing Partner, Strategy ***** et Managers
#sports #Friday #library #california
3 days ago
Bunker fuel prices for ships remain at historically elevated levels, keeping pressure on vessel operating costs even as the marine-fuel supply squeeze that followed disruption around the Strait of Hormuz has eased at major fueling hubs.
In Singapore, the world's largest bunkering center, very-low-sulphur fuel oil, or VLSFO, was ******* sed at about $908 per metric ton this week, while marine gasoil (MGO) stood at $1,448 per ton and high-sulphur fuel oil at roughly $770 per ton, according to ******* yst Ship & Bunker.
At Rotterdam, Europe's busiest port, VLSFO was about $731 per ton, compared with $804 per ton in Houston and $1,005 per ton in Fujairah, United Arab Emirates.
The premium at Fujairah, the Middle East's principal bunker hub, shows the continuing impact of constrained traffic and supply-chain disruption in and around the Strait of Hormuz. Bunkering activity at Fujairah has recovered to about 40% of its prewar level, according to industry comments reported from the Asia Pacific Petroleum Conference, but remains well below normal.
Costs still far above January
#fuel #strait #hormuz #supply
In Singapore, the world's largest bunkering center, very-low-sulphur fuel oil, or VLSFO, was ******* sed at about $908 per metric ton this week, while marine gasoil (MGO) stood at $1,448 per ton and high-sulphur fuel oil at roughly $770 per ton, according to ******* yst Ship & Bunker.
At Rotterdam, Europe's busiest port, VLSFO was about $731 per ton, compared with $804 per ton in Houston and $1,005 per ton in Fujairah, United Arab Emirates.
The premium at Fujairah, the Middle East's principal bunker hub, shows the continuing impact of constrained traffic and supply-chain disruption in and around the Strait of Hormuz. Bunkering activity at Fujairah has recovered to about 40% of its prewar level, according to industry comments reported from the Asia Pacific Petroleum Conference, but remains well below normal.
Costs still far above January
#fuel #strait #hormuz #supply
3 days ago
By Lucia Mutikani
WASHINGTON, Sept 16 (Reuters) - U.S. retail sales rebounded sharply in August as households boosted purchases of a range of goods while also spending more at restaurants and bars, reinforcing the economy's resilience even as consumers grow more anxious about high inflation.
The stronger-than-expected report from the Commerce Department on Wednesday prompted economists to upgrade their gross domestic product growth estimates for the third quarter. Inflation jitters were underscored by news of a surge in import prices last month amid strong increases in the costs of capital and consumer goods.
The reports followed data this month showing producer and consumer prices accelerated in August, while the labor market regained its poise after wobbling through much of summer.
The Federal Reserve on Wednesday raised its benchmark overnight interest rate by a quarter of a percentage point to the 3.75%-4.00% range and flagged further increases in borrowing costs in the months ahead.
#inflation #quarter
WASHINGTON, Sept 16 (Reuters) - U.S. retail sales rebounded sharply in August as households boosted purchases of a range of goods while also spending more at restaurants and bars, reinforcing the economy's resilience even as consumers grow more anxious about high inflation.
The stronger-than-expected report from the Commerce Department on Wednesday prompted economists to upgrade their gross domestic product growth estimates for the third quarter. Inflation jitters were underscored by news of a surge in import prices last month amid strong increases in the costs of capital and consumer goods.
The reports followed data this month showing producer and consumer prices accelerated in August, while the labor market regained its poise after wobbling through much of summer.
The Federal Reserve on Wednesday raised its benchmark overnight interest rate by a quarter of a percentage point to the 3.75%-4.00% range and flagged further increases in borrowing costs in the months ahead.
#inflation #quarter
3 days ago
GE Vernova Inc (NYSE:GEV) rebounded with Bernstein's backing after an earlier sell-off that followed broader concerns about technology infrastructure spending.
Shares were up 6% at $933.94 during afternoon trading on Wednesday, outpacing the utilities sector's reported 1.24% advance.
GE Vernova also ranked among the three leading stocks by turnover in the utilities sector as its shares recovered from prior-session declines.
Bernstein reaffirmed its "outperform" rating, highlighting electrification demand beyond immediate artificial intelligence data center needs.
The brokerage said utility-driven power grid upgrades, energy security and decarbonization initiatives accounted for the majority of electrification orders.
#backing
Shares were up 6% at $933.94 during afternoon trading on Wednesday, outpacing the utilities sector's reported 1.24% advance.
GE Vernova also ranked among the three leading stocks by turnover in the utilities sector as its shares recovered from prior-session declines.
Bernstein reaffirmed its "outperform" rating, highlighting electrification demand beyond immediate artificial intelligence data center needs.
The brokerage said utility-driven power grid upgrades, energy security and decarbonization initiatives accounted for the majority of electrification orders.
#backing
3 days ago
US stock index futures pointed to a higher opening on Wednesday as crude oil prices declined and investors awaited the Federal Reserve's interest rate decision later in the day.
The indicated rebound followed two consecutive sessions of losses that pushed the S&P 500 to its lowest closing level in more than a month.
US crude oil futures fell nearly 2% after gaining almost 6% over the previous two days. The decline followed an American Petroleum Institute report showing an unexpected increase of 7.1 million barrels in US crude oil inventories last week.
Trading activity could remain limited ahead of the Federal Reserve's monetary policy announcement.
According to CME Group's FedWatch Tool, market pricing indicated a 92.7% probability of a 25-basis-point interest rate increase. The figure reflects market-implied expectations rather than a confirmed policy decision.
#increase
The indicated rebound followed two consecutive sessions of losses that pushed the S&P 500 to its lowest closing level in more than a month.
US crude oil futures fell nearly 2% after gaining almost 6% over the previous two days. The decline followed an American Petroleum Institute report showing an unexpected increase of 7.1 million barrels in US crude oil inventories last week.
Trading activity could remain limited ahead of the Federal Reserve's monetary policy announcement.
According to CME Group's FedWatch Tool, market pricing indicated a 92.7% probability of a 25-basis-point interest rate increase. The figure reflects market-implied expectations rather than a confirmed policy decision.
#increase
4 days ago
A public company typically has limited control over third-party financial products that reference its shares, but Robinhood Markets, Inc. (NASDAQ:HOOD) and AMC Entertainment Holdings, Inc. (NYSE:AMC) are now testing that notion in public, in one of the year's most intense corporate spats. The debate revolves over stock tokens and has evolved from a heated social media post on September 3 to a live televised retort by September 9.
Robinhood Markets, Inc. (NASDAQ:HOOD) expanded its tokenized shares offering, which is issued through a unit named Robinhood ****** ets (Jersey) Limited and traded on Robinhood's proprietary blockchain, Robinhood Chain, to include over 190 public firms, including AMC, without the companies directly signing on. When AMC CEO Adam Aron discovered that his company was among them, he did not mince words. On September 3, Aron posted on X, calling the practice "contemptible, outrageous, disgusting, detestable, inexcusable, vile," questioning how it could possibly be legal, and stating that AMC Entertainment Holdings, Inc. (NYSE:AMC) had no relation to the tokens and did not condone them.
He stated that the company would retain independent securities counsel and vowed to take the matter to the SEC, characterizing Robinhood's tokens as an unregistered securities product that undermines the regular relationship between a public company and its shareholders.
The market reaction was fast and telling: AMC shares rose as much as 21% in overnight trading after the public dispute broke out.
Robinhood did not back down. In the days that followed, the company's chief legal officer, Dan Gallagher, a former SEC commissioner, mocked the tone of Aron's complaint on social media, saying Robinhood "know[s] a little something about the US securities laws," and inviting AMC's lawyers to contact them. CEO Vlad Tenev originally commented on X with a brief "What's the concern?" before making his first extensive, broadcast comments on the controversy in a CNBC "Squawk Box" interview on September 9.
#company
Robinhood Markets, Inc. (NASDAQ:HOOD) expanded its tokenized shares offering, which is issued through a unit named Robinhood ****** ets (Jersey) Limited and traded on Robinhood's proprietary blockchain, Robinhood Chain, to include over 190 public firms, including AMC, without the companies directly signing on. When AMC CEO Adam Aron discovered that his company was among them, he did not mince words. On September 3, Aron posted on X, calling the practice "contemptible, outrageous, disgusting, detestable, inexcusable, vile," questioning how it could possibly be legal, and stating that AMC Entertainment Holdings, Inc. (NYSE:AMC) had no relation to the tokens and did not condone them.
He stated that the company would retain independent securities counsel and vowed to take the matter to the SEC, characterizing Robinhood's tokens as an unregistered securities product that undermines the regular relationship between a public company and its shareholders.
The market reaction was fast and telling: AMC shares rose as much as 21% in overnight trading after the public dispute broke out.
Robinhood did not back down. In the days that followed, the company's chief legal officer, Dan Gallagher, a former SEC commissioner, mocked the tone of Aron's complaint on social media, saying Robinhood "know[s] a little something about the US securities laws," and inviting AMC's lawyers to contact them. CEO Vlad Tenev originally commented on X with a brief "What's the concern?" before making his first extensive, broadcast comments on the controversy in a CNBC "Squawk Box" interview on September 9.
#company
4 days ago
Pfizer Inc. (NYSE:PFE) and Valneva SE (NASDAQ:VALN) reported on August 14 that the European Medicines Agency has validated the Marketing Authorization Application for PF-07307405, the companies' experimental Lyme disease vaccine candidate, and will now begin the official review.
For a vaccine candidate first proposed in a 2020 collaboration deal between Pfizer Inc. (NYSE:PFE) and French biotech Valneva SE (NASDAQ:VALN), this represents the formal transition from years of clinical development into European regulatory review.
The application is based on the Phase 3 VALOR trial, a placebo-controlled, randomized study of 9,437 participants aged five and older from high-incidence Lyme disease locations in US, Canada, and Europe. Participants got four doses on a phased schedule: one at months 0, 2, and 5-9, followed by a fourth dosage around a year later, shortly before the start of the next Lyme season. Topline data released in March 2026 demonstrated efficacy of over 70% in reducing confirmed Lyme disease cases, with the vaccine generally tolerated and no safety issues detected. However, the statistical picture was less clean than the headline efficacy suggests. The first prespecified **** ysis, which served as the primary endpoint, showed 73.2% efficacy but failed the trial's predefined statistical criterion because the lower bound of the 95% confidence interval was 15.8%, below the required 20%. A second prespecified **** ysis showed 74.8% efficacy and did meet that threshold.
Valneva SE (NASDAQ:VALN), the smallest of the two partners, views the vaccine as a clean competitive setup. According to the company, PF-07307405 is the most advanced Lyme disease vaccine candidate currently in clinical development, a rare spot in the vaccine industry where new entrants often face competition from existing treatments. Under the terms of the 2020 partnership and license agreement, Pfizer Inc. (NYSE:PFE) will have exclusive rights to produce and commercialize the vaccine if it is approved, while Valneva SE (NASDAQ:VALN) will benefit as a development partner.
The institutional stance is very different between the two companies, reflecting their very different sizes. Pfizer Inc. (NYSE:PFE) is still a strong name in the institutional **** e, with hedge fund ownership stable at 83 funds in the second quarter of 2026, the same as the first quarter, reflecting its position as a large, diversified pharmaceutical holding, rather than a name driven by a specific pipeline event. Valneva SE (NASDAQ:VALN), however, has little hedge fund exposure, with only 4 funds holding a position in the second quarter, up from 1 in the first quarter, reflecting the continued lack of visibility of the smaller partner among institutional investors.
#vaccine #pfizer #NYSE
For a vaccine candidate first proposed in a 2020 collaboration deal between Pfizer Inc. (NYSE:PFE) and French biotech Valneva SE (NASDAQ:VALN), this represents the formal transition from years of clinical development into European regulatory review.
The application is based on the Phase 3 VALOR trial, a placebo-controlled, randomized study of 9,437 participants aged five and older from high-incidence Lyme disease locations in US, Canada, and Europe. Participants got four doses on a phased schedule: one at months 0, 2, and 5-9, followed by a fourth dosage around a year later, shortly before the start of the next Lyme season. Topline data released in March 2026 demonstrated efficacy of over 70% in reducing confirmed Lyme disease cases, with the vaccine generally tolerated and no safety issues detected. However, the statistical picture was less clean than the headline efficacy suggests. The first prespecified **** ysis, which served as the primary endpoint, showed 73.2% efficacy but failed the trial's predefined statistical criterion because the lower bound of the 95% confidence interval was 15.8%, below the required 20%. A second prespecified **** ysis showed 74.8% efficacy and did meet that threshold.
Valneva SE (NASDAQ:VALN), the smallest of the two partners, views the vaccine as a clean competitive setup. According to the company, PF-07307405 is the most advanced Lyme disease vaccine candidate currently in clinical development, a rare spot in the vaccine industry where new entrants often face competition from existing treatments. Under the terms of the 2020 partnership and license agreement, Pfizer Inc. (NYSE:PFE) will have exclusive rights to produce and commercialize the vaccine if it is approved, while Valneva SE (NASDAQ:VALN) will benefit as a development partner.
The institutional stance is very different between the two companies, reflecting their very different sizes. Pfizer Inc. (NYSE:PFE) is still a strong name in the institutional **** e, with hedge fund ownership stable at 83 funds in the second quarter of 2026, the same as the first quarter, reflecting its position as a large, diversified pharmaceutical holding, rather than a name driven by a specific pipeline event. Valneva SE (NASDAQ:VALN), however, has little hedge fund exposure, with only 4 funds holding a position in the second quarter, up from 1 in the first quarter, reflecting the continued lack of visibility of the smaller partner among institutional investors.
#vaccine #pfizer #NYSE
4 days ago
The yuan-denominated crude oil futures trading in China hit this week their highest level since the contract was launched in 2018 as escalating threats to Middle East's oil supply and increased purchases by Chinese refiners push prices higher.
Launched in March 2018, the INE crude oil futures contract (SC) is a physical-settlement contract priced and traded in Chinese yuan on the Shanghai International Energy Exchange.
The crude futures soared to as much as 929.4 yuan, or $138.50 per barrel, on the exchange, according to data compiled by Bloomberg.
The price spike followed the intensified concerns about supply from the Middle East after the East-West oil pipeline in Saudi Arabia was attacked by drones late last week, forcing the Kingdom to temporarily shut it down.
The international crude oil benchmarks also rallied at the start of this week. As of Tuesday, no timeline has been given as to when the pipeline would come back and continue helping Saudi Arabia bypass the Strait of Hormuz with shipments out of the Red Sea port of Yanbu.
#contract #east #saudi
Launched in March 2018, the INE crude oil futures contract (SC) is a physical-settlement contract priced and traded in Chinese yuan on the Shanghai International Energy Exchange.
The crude futures soared to as much as 929.4 yuan, or $138.50 per barrel, on the exchange, according to data compiled by Bloomberg.
The price spike followed the intensified concerns about supply from the Middle East after the East-West oil pipeline in Saudi Arabia was attacked by drones late last week, forcing the Kingdom to temporarily shut it down.
The international crude oil benchmarks also rallied at the start of this week. As of Tuesday, no timeline has been given as to when the pipeline would come back and continue helping Saudi Arabia bypass the Strait of Hormuz with shipments out of the Red Sea port of Yanbu.
#contract #east #saudi
4 days ago
Pfizer Inc. (NYSE:PFE) and Valneva SE (NASDAQ:VALN) reported on August 14 that the European Medicines Agency has validated the Marketing Authorization Application for PF-07307405, the companies' experimental Lyme disease vaccine candidate, and will now begin the official review.
For a vaccine candidate first proposed in a 2020 collaboration deal between Pfizer Inc. (NYSE:PFE) and French biotech Valneva SE (NASDAQ:VALN), this represents the formal transition from years of clinical development into European regulatory review.
The application is based on the Phase 3 VALOR trial, a placebo-controlled, randomized study of 9,437 participants aged five and older from high-incidence Lyme disease locations in US, Canada, and Europe. Participants got four doses on a phased schedule: one at months 0, 2, and 5-9, followed by a fourth dosage around a year later, shortly before the start of the next Lyme season. Topline data released in March 2026 demonstrated efficacy of over 70% in reducing confirmed Lyme disease cases, with the vaccine generally tolerated and no safety issues detected. However, the statistical picture was less clean than the headline efficacy suggests. The first prespecified **** ysis, which served as the primary endpoint, showed 73.2% efficacy but failed the trial's predefined statistical criterion because the lower bound of the 95% confidence interval was 15.8%, below the required 20%. A second prespecified **** ysis showed 74.8% efficacy and did meet that threshold.
Valneva SE (NASDAQ:VALN), the smallest of the two partners, views the vaccine as a clean competitive setup. According to the company, PF-07307405 is the most advanced Lyme disease vaccine candidate currently in clinical development, a rare spot in the vaccine industry where new entrants often face competition from existing treatments. Under the terms of the 2020 partnership and license agreement, Pfizer Inc. (NYSE:PFE) will have exclusive rights to produce and commercialize the vaccine if it is approved, while Valneva SE (NASDAQ:VALN) will benefit as a development partner.
The institutional stance is very different between the two companies, reflecting their very different sizes. Pfizer Inc. (NYSE:PFE) is still a strong name in the institutional **** e, with hedge fund ownership stable at 83 funds in the second quarter of 2026, the same as the first quarter, reflecting its position as a large, diversified pharmaceutical holding, rather than a name driven by a specific pipeline event. Valneva SE (NASDAQ:VALN), however, has little hedge fund exposure, with only 4 funds holding a position in the second quarter, up from 1 in the first quarter, reflecting the continued lack of visibility of the smaller partner among institutional investors.
#disease
For a vaccine candidate first proposed in a 2020 collaboration deal between Pfizer Inc. (NYSE:PFE) and French biotech Valneva SE (NASDAQ:VALN), this represents the formal transition from years of clinical development into European regulatory review.
The application is based on the Phase 3 VALOR trial, a placebo-controlled, randomized study of 9,437 participants aged five and older from high-incidence Lyme disease locations in US, Canada, and Europe. Participants got four doses on a phased schedule: one at months 0, 2, and 5-9, followed by a fourth dosage around a year later, shortly before the start of the next Lyme season. Topline data released in March 2026 demonstrated efficacy of over 70% in reducing confirmed Lyme disease cases, with the vaccine generally tolerated and no safety issues detected. However, the statistical picture was less clean than the headline efficacy suggests. The first prespecified **** ysis, which served as the primary endpoint, showed 73.2% efficacy but failed the trial's predefined statistical criterion because the lower bound of the 95% confidence interval was 15.8%, below the required 20%. A second prespecified **** ysis showed 74.8% efficacy and did meet that threshold.
Valneva SE (NASDAQ:VALN), the smallest of the two partners, views the vaccine as a clean competitive setup. According to the company, PF-07307405 is the most advanced Lyme disease vaccine candidate currently in clinical development, a rare spot in the vaccine industry where new entrants often face competition from existing treatments. Under the terms of the 2020 partnership and license agreement, Pfizer Inc. (NYSE:PFE) will have exclusive rights to produce and commercialize the vaccine if it is approved, while Valneva SE (NASDAQ:VALN) will benefit as a development partner.
The institutional stance is very different between the two companies, reflecting their very different sizes. Pfizer Inc. (NYSE:PFE) is still a strong name in the institutional **** e, with hedge fund ownership stable at 83 funds in the second quarter of 2026, the same as the first quarter, reflecting its position as a large, diversified pharmaceutical holding, rather than a name driven by a specific pipeline event. Valneva SE (NASDAQ:VALN), however, has little hedge fund exposure, with only 4 funds holding a position in the second quarter, up from 1 in the first quarter, reflecting the continued lack of visibility of the smaller partner among institutional investors.
#disease
4 days ago
The yuan-denominated crude oil futures trading in China hit this week their highest level since the contract was launched in 2018 as escalating threats to Middle East's oil supply and increased purchases by Chinese refiners push prices higher.
Launched in March 2018, the INE crude oil futures contract (SC) is a physical-settlement contract priced and traded in Chinese yuan on the Shanghai International Energy Exchange.
The crude futures soared to as much as 929.4 yuan, or $138.50 per barrel, on the exchange, according to data compiled by Bloomberg.
The price spike followed the intensified concerns about supply from the Middle East after the East-West oil pipeline in Saudi Arabia was attacked by drones late last week, forcing the Kingdom to temporarily shut it down.
The international crude oil benchmarks also rallied at the start of this week. As of Tuesday, no timeline has been given as to when the pipeline would come back and continue helping Saudi Arabia bypass the Strait of Hormuz with shipments out of the Red Sea port of Yanbu.
#crude #futures #middle #saudi
Launched in March 2018, the INE crude oil futures contract (SC) is a physical-settlement contract priced and traded in Chinese yuan on the Shanghai International Energy Exchange.
The crude futures soared to as much as 929.4 yuan, or $138.50 per barrel, on the exchange, according to data compiled by Bloomberg.
The price spike followed the intensified concerns about supply from the Middle East after the East-West oil pipeline in Saudi Arabia was attacked by drones late last week, forcing the Kingdom to temporarily shut it down.
The international crude oil benchmarks also rallied at the start of this week. As of Tuesday, no timeline has been given as to when the pipeline would come back and continue helping Saudi Arabia bypass the Strait of Hormuz with shipments out of the Red Sea port of Yanbu.
#crude #futures #middle #saudi